当前位置:
X-MOL 学术
›
Neurogastroenterol. Motil.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty
Neurogastroenterology & Motility ( IF 3.5 ) Pub Date : 2021-08-11 , DOI: 10.1111/nmo.14210 Maria S Svane 1, 2 , Caroline C Øhrstrøm 3 , Astrid Plamboeck 4 , Nils B Jørgensen 1 , Kirstine N Bojsen-Møller 1, 2 , Carsten Dirksen 1 , Christoffer Martinussen 1, 2 , Tina Vilsbøll 5, 6, 7 , Bolette Hartmann 2, 4 , Carolyn F Deacon 4 , Viggo B Kristiansen 8 , Filip K Knop 2, 5, 6, 7 , Lars B Svendsen 9 , Sten Madsbad 1, 2, 4 , Jens J Holst 2, 4 , Simon Veedfald 1, 4
Neurogastroenterology & Motility ( IF 3.5 ) Pub Date : 2021-08-11 , DOI: 10.1111/nmo.14210 Maria S Svane 1, 2 , Caroline C Øhrstrøm 3 , Astrid Plamboeck 4 , Nils B Jørgensen 1 , Kirstine N Bojsen-Møller 1, 2 , Carsten Dirksen 1 , Christoffer Martinussen 1, 2 , Tina Vilsbøll 5, 6, 7 , Bolette Hartmann 2, 4 , Carolyn F Deacon 4 , Viggo B Kristiansen 8 , Filip K Knop 2, 5, 6, 7 , Lars B Svendsen 9 , Sten Madsbad 1, 2, 4 , Jens J Holst 2, 4 , Simon Veedfald 1, 4
Affiliation
Neurotensin (NT) is released from enteroendocrine cells and lowers food intake in rodents. We evaluated postprandial NT secretion in humans after surgeries associated with accelerated small intestinal nutrient delivery, and after Roux-en-Y gastric bypass (RYGB) when glucagon-like peptide-1 (GLP-1) signalling and dipeptidyl peptidase 4 (DPP-4) were inhibited, and during pharmacological treatments influencing entero-pancreatic functions.
中文翻译:
Roux-en-Y 胃旁路术、袖状胃切除术和躯干迷走神经切断术联合幽门成形术后的神经降压素分泌
神经降压素 (NT) 从肠内分泌细胞中释放出来并降低啮齿动物的食物摄入量。我们评估了与加速小肠营养输送相关的手术后人类餐后 NT 分泌,以及当胰高血糖素样肽-1 (GLP-1) 信号传导和二肽基肽酶 4 (DPP-4) 时的 Roux-en-Y 胃绕道 (RYGB) ) 受到抑制,并且在影响肠胰功能的药物治疗期间。
更新日期:2021-08-11
中文翻译:
Roux-en-Y 胃旁路术、袖状胃切除术和躯干迷走神经切断术联合幽门成形术后的神经降压素分泌
神经降压素 (NT) 从肠内分泌细胞中释放出来并降低啮齿动物的食物摄入量。我们评估了与加速小肠营养输送相关的手术后人类餐后 NT 分泌,以及当胰高血糖素样肽-1 (GLP-1) 信号传导和二肽基肽酶 4 (DPP-4) 时的 Roux-en-Y 胃绕道 (RYGB) ) 受到抑制,并且在影响肠胰功能的药物治疗期间。